ipamorelin dosage for muscle growth: Frequently asked questions

Increase frequency to three doses daily (morning, afternoon, pre-bed) rather than increasing dose per injection. GH secretion is pulse-dependent, not dose-dependent beyond the 200–300mcg threshold. Adding a third pulse generates more cumulative IGF-1 exposure than doubling a single dose. Verify fasted-state adherence: even a small protein shake 90 minutes before dosing can suppress GH secretion by 30–40%. If gains remain absent after adding a third pulse and confirming fasted timing, the issue is likely training stimulus or caloric intake, not peptide efficacy.

The dose won't be harmful, but GH pulse amplitude will be significantly blunted. Potentially 50–60% lower than fasted-state administration due to elevated insulin and glucose suppressing pituitary GH release. Don't double the next dose to compensate. Simply resume the normal schedule at the next planned fasted-state injection. Consistency across multiple properly timed doses matters far more than recovering one suboptimal pulse.

Receptor desensitization becomes inevitable. Studies on chronic GH secretagogue administration show measurable declines in GH pulse amplitude starting around week 10–12 of continuous use as GHS-R1a density decreases in response to sustained stimulation. You can continue dosing, but diminishing returns mean you're administering peptide without proportional anabolic benefit. The 4-week washout restores receptor density to baseline. Skipping it turns an 8-week high-efficacy protocol into a 16-week moderate-efficacy protocol with double the cost.

Joint pain at 100mcg per peptide three times daily suggests either pre-existing mild arthritis that GH-induced fluid retention is exacerbating, or an unusually high endogenous GH response creating supraphysiological total exposure. Reduce frequency to twice daily (morning and evening only, eliminating the post-workout dose) and assess symptoms over two weeks. If pain persists, decrease individual injection doses to 75mcg while maintaining twice-daily frequency. Joint discomfort that doesn't resolve with dose reduction warrants discontinuation and medical evaluation. It may indicate underlying pathology unrelated to the peptides.

Confirm that injections are being administered in a fasted state. Insulin antagonism is the most common cause of blunted IGF-1 response in protocols with correct dosing and timing. Verify peptide storage conditions: CJC-1295 no DAC and Ipamorelin must be stored at 2-8°C after reconstitution, and any temperature excursion above 25°C for more than two hours causes irreversible degradation. If storage and timing are correct, consider increasing injection frequency to four times daily (upon waking, mid-morning, post-workout, before sleep) at the same 100mcg per peptide dose before escalating individual injection amounts. Pulse frequency often matters more than pulse magnitude for IGF-1 synthesis.

Administer the dose as soon as you remember if fewer than four hours have passed since training completion. GH receptor upregulation persists for 2-4 hours post-exercise, so delayed administration within this window still captures most of the anabolic benefit. If more than four hours have elapsed, skip the missed dose entirely and continue with your evening injection. Doubling up creates an abnormally large pulse that promotes GH receptor desensitization rather than enhanced muscle growth.